Rigel to Participate in Upcoming September Investor Conferences
Rigel Pharmaceuticals (NASDAQ:RIGL), a biotechnology company focused on hematologic disorders and cancer, has announced its participation in four major investor conferences this September 2025.
The company's leadership, including CEO Raul Rodriguez and CFO Dean Schorno, will attend the Citi's Biopharma Back to School Conference, Cantor Global Healthcare Conference, Wells Fargo Healthcare Conference, and H.C. Wainwright Global Investment Conference. Company presentations are scheduled at Cantor (September 3, 8:35 a.m. ET) and H.C. Wainwright (September 9, 1:30 p.m. ET), with webcasts available through Rigel's investor relations website.
Rigel Pharmaceuticals (NASDAQ:RIGL), una societ脿 biotecnologica specializzata in disturbi ematologici e oncologia, ha annunciato la propria partecipazione a quattro importanti conferenze per investitori previste per settembre 2025.
La direzione dell'azienda, tra cui l'amministratore delegato Raul Rodriguez e il direttore finanziario Dean Schorno, prender脿 parte al Citi's Biopharma Back to School Conference, al Cantor Global Healthcare Conference, al Wells Fargo Healthcare Conference e all'H.C. Wainwright Global Investment Conference. Le presentazioni aziendali sono programmate al Cantor (3 settembre, 8:35 a.m. ET) e all'H.C. Wainwright (9 settembre, 1:30 p.m. ET), con webcast disponibili sul sito degli investitori di Rigel.
Rigel Pharmaceuticals (NASDAQ:RIGL), una compa帽铆a biotecnol贸gica centrada en trastornos hematol贸gicos y c谩ncer, ha anunciado su participaci贸n en cuatro importantes conferencias para inversores en septiembre de 2025.
La direcci贸n de la empresa, incluidos el CEO Raul Rodriguez y el CFO Dean Schorno, asistir谩 al Citi's Biopharma Back to School Conference, al Cantor Global Healthcare Conference, al Wells Fargo Healthcare Conference y al H.C. Wainwright Global Investment Conference. Las presentaciones de la compa帽铆a est谩n programadas en Cantor (3 de septiembre, 8:35 a.m. ET) y en H.C. Wainwright (9 de septiembre, 1:30 p.m. ET), y habr谩 retransmisiones web disponibles en el sitio de relaciones con inversores de Rigel.
Rigel Pharmaceuticals (NASDAQ:RIGL)電� 順堨暋 歆堩櫂 氚� 鞎旍潉 鞝勲鞙茧 頃橂姅 氚旍澊鞓ろ厡韥� 旮办梾鞙茧, 2025雲� 9鞗旍棎 鞐措Μ電� 雱� 瓯挫潣 欤检殧 韴瀽鞛� 旎嵓霟办姢鞐� 彀戈皜頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟.
CEO Raul Rodriguez鞕� CFO Dean Schorno毳� 韽暔頃� 瓴届榿歆勳澊 Citi's Biopharma Back to School Conference, Cantor Global Healthcare Conference, Wells Fargo Healthcare Conference, H.C. Wainwright Global Investment Conference鞐� 彀胳劃頃╇媹雼�. 須岇偓 氚滍憸電� Cantor鞐愳劀(9鞗� 3鞚�, 鞓れ爠 8:35 ET)瓿� H.C. Wainwright鞐愳劀(9鞗� 9鞚�, 鞓ろ泟 1:30 ET)鞐� 鞓堨爼霅橃柎 鞛堨溂氅�, Rigel 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼毳� 韱淀暣 鞗轨簮鞀ろ姼搿� 鞁滌箔頃� 靾� 鞛堨姷雼堧嫟.
Rigel Pharmaceuticals (NASDAQ:RIGL), une soci茅t茅 de biotechnologie sp茅cialis茅e dans les troubles h茅matologiques et le cancer, a annonc茅 sa participation 脿 quatre grandes conf茅rences pour investisseurs en septembre 2025.
La direction de l'entreprise, y compris le PDG Raul Rodriguez et le directeur financier Dean Schorno, assistera au Citi's Biopharma Back to School Conference, au Cantor Global Healthcare Conference, au Wells Fargo Healthcare Conference et au H.C. Wainwright Global Investment Conference. Les pr茅sentations de la soci茅t茅 sont programm茅es chez Cantor (3 septembre, 8:35 a.m. ET) et chez H.C. Wainwright (9 septembre, 1:30 p.m. ET), avec des webcasts disponibles via le site des relations investisseurs de Rigel.
Rigel Pharmaceuticals (NASDAQ:RIGL), ein Biotechnologieunternehmen mit Schwerpunkt auf h盲matologischen Erkrankungen und Krebs, hat seine Teilnahme an vier wichtigen Investorenkonferenzen im September 2025 angek眉ndigt.
Die Unternehmensf眉hrung, darunter CEO Raul Rodriguez und CFO Dean Schorno, wird an der Citi's Biopharma Back to School Conference, der Cantor Global Healthcare Conference, der Wells Fargo Healthcare Conference und der H.C. Wainwright Global Investment Conference teilnehmen. Unternehmenspr盲sentationen sind bei Cantor (3. September, 8:35 a.m. ET) und H.C. Wainwright (9. September, 1:30 p.m. ET) geplant; Webcasts werden 眉ber die Investor-Relations-Website von Rigel verf眉gbar sein.
- None.
- None.
- Citi's 2025 Biopharma Back to School Conference in
Boston, MA
Rigel will participate in one-on-one meetings on Tuesday, September 2. - Cantor Global Healthcare Conference 2025 in
New York, NY
Rigel will participate in one-on-one meetings and present a company overview on Wednesday, September 3, at 8:35 a.m. ET. - 2025 Wells Fargo Healthcare Conference in
Boston, MA
Rigel will participate in one-on-one meetings on Thursday, September 4. - H.C. Wainwright 27th Annual Global Investment Conference in
New York, NY
Rigel will participate in one-on-one meetings and present a company overview on Tuesday, September 9, at 1:30 p.m. ET.
To access the live webcasts or archived recordings of the Cantor and H.C. Wainwright Conference presentations, visit the Investor Relations section of the company's website at . Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.
About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in
Contact for Investors & Media:
Investors:听
Rigel Pharmaceuticals, Inc.听
650.624.1232听
[email protected]
Media:听
David Rosen听
Argot Partners听
646.461.6387
[email protected]听
听
View original content to download multimedia:
SOURCE Rigel Pharmaceuticals, Inc.
FAQ
When is Rigel Pharmaceuticals (RIGL) presenting at the Cantor Global Healthcare Conference 2025?
How can investors access Rigel's (RIGL) conference presentations in September 2025?
Which investor conferences is Rigel Pharmaceuticals (RIGL) attending in September 2025?
Who will represent Rigel Pharmaceuticals (RIGL) at the September 2025 investor conferences?
